Yıl: 2023 Cilt: 20 Sayı: 2 Sayfa Aralığı: 120 - 125 Metin Dili: İngilizce DOI: 10.4274/tjod.galenos.2023.26037 İndeks Tarihi: 07-06-2023

Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study

Öz:
Objective: The purpose of this research is to investigate the relationship between zonulin levels and diminished ovarian reserve (DOR), and to evaluate the potential role of autoimmunity in the development of DOR. The study contributes to the understanding of the pathogenesis of DOR, which can be an unexpected diagnosis often associated with infertility and unpleasant physical symptoms in women. Materials and Methods: This cross-sectional study was conducted by scanning 224 patients. The demographic characteristics of the patients were recorded. Antral follicle counts of the patients were determined by ultrasound, and Anti-Mullerian hormone (AMH) levels were examined. Follicle-stimulating hormone (FSH), luteinizing hormone, estradiol, AMH measurement, and antral follicle counts were made on the 2nd or 3rd day of menstrual bleeding. The zonulin levels of the participants were measured by the ELISA method. The patients were divided into two groups according to the presence of DOR. The patients’ demographic characteristics and hormone levels were compared between these two groups, serum zonulin levels were examined, and the relationship between other hormone parameters and zonulin was investigated. Results: When the median ages of the patients in both groups were compared, the median age of patients with DOR was 38 years, significantly higher (p<0.001) than the median age of those without DOR, which was 27 years. The median zonulin levels of both groups were compare; it was observed that it was 19.71 ng/mL in the group with DOR and 11.03 ng/mL without DOR, and a statistically significant difference was found between the zonulin levels of the patients in both groups (p<0.001). A moderate inverse correlation (p<0.001) between patients’ zonulin and AMH levels, and a moderate correlation between FSH levels (p<0.001). Conclusion: In conclusion, zonulin levels of patients with DOR were higher than women without DOR. Evaluation of zonulin levels may also be considered during the diagnosis of DOR.
Anahtar Kelime:

Azalan yumurtalık rezervi için potansiyel bir biyobelirteç olarak zonulin: Prospektif bir çalışma

Öz:
Amaç: Bu araştırmanın amacı, zonulin düzeyleri ile azalmış over rezervi (DOR) arasındaki ilişkiyi ve otoimmünitenin DOR gelişimindeki potansiyel rolünü değerlendirmektir. Çalışma, kadınlar için sıkıntılı fiziksel semptomlar ve infertilite ile ilişkili beklenmedik bir teşhis olan DOR patogenezinin anlaşılmasına katkıda bulunmayı amaçlamaktadır. Gereç ve Yöntemler: Bu kesitsel çalışma, 224 hastanın taranmasıyla gerçekleştirildi. Hastaların demografik özellikleri kaydedildi. Hastaların antral folikül sayıları ultrason ile belirlendi ve Anti-Müllerian hormon (AMH) düzeyleri incelendi. Folikül uyarıcı hormon (FSH), luteinleştirici hormon, östradiol, AMH ölçümü ve antral folikül sayıları, menstrüel kanamanın 2. veya 3. gününde yapıldı. Katılımcıların zonulin düzeyleri ELISA yöntemiyle ölçüldü. Hastalar, DOR varlığına göre iki gruba ayrıldı. Bu iki grup arasında hastaların demografik özellikleri ve hormon düzeyleri karşılaştırıldı, serum zonulin düzeyleri incelendi ve diğer hormon parametreleri ile zonulin arasındaki ilişki araştırıldı. Bulgular: Her iki grup hastaların ortanca yaşları karşılaştırıldığında, DOR olan hastaların ortanca yaşı 38 yıl iken, DOR olmayan hastaların ortanca yaşı olan 27 yıldan önemli ölçüde yüksek (p<0,001) olduğu görüldü. Her iki grup hastaların ortanca zonulin düzeyleri karşılaştırıldığında, DOR olan grupta 19,71 ng/mL ve DOR olmayan grupta 11,03 ng/mL olarak bulundu ve her iki grup hastaların zonulin düzeyleri arasında istatistiksel olarak anlamlı bir fark bulundu (p<0,001). Hastaların zonulin düzeyleri ile AMH düzeyleri arasında orta derecede ters bir korelasyon (p<0,001) ve FSH düzeyleri ile orta derecede bir korelasyon bulundu (p<0,001). Sonuç: DOR olan hastaların zonulin düzeyleri, DOR olmayan kadınlardan daha yüksek bulundu. DOR tanısı sırasında zonulin düzeylerinin değerlendirilmesi de dikkate alınabilir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Levi AJ, Raynault MF, Bergh PA, Drews MR, Miller BT, Scott RT Jr. Reproductive outcome in patients with diminished ovarian reserve. Fertil Steril 2001;76:666-9.
  • 2. Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod 2008;23:699-708.
  • 3. Pastore LM, Christianson MS, Stelling J, Kearns WG, Segars JH. Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR. J Assist Reprod Genet 2018;35:17-23.
  • 4. Sharara FI, Scott RT Jr, Seifer DB. The detection of diminished ovarian reserve in infertile women. Am J Obstet Gynecol 1998;179:804-12.
  • 5. Sunderam S, Kissin DM, Zhang Y, Jewett A, Boulet SL, Warner L, et al. Assisted Reproductive Technology Surveillance - United States, 2018. MMWR Surveill Summ 2022;71:1-19.
  • 6. Luisi S, Orlandini C, Regini C, Pizzo A, Vellucci F, Petraglia F. Premature ovarian insufficiency: from pathogenesis to clinical management. J Endocrinol Invest 2015;38:597-603.
  • 7. Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev 2009;30:465-93.
  • 8. Di Pierro M, Lu R, Uzzau S, Wang W, Margaretten K, Pazzani C, et al. Zonula occludens toxin structure-function analysis. Identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain. J Biol Chem 2001;276:19160-5.
  • 9. Fasano A. Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. Am J Pathol 2008;173:1243-52.
  • 10. Bona MD, Torres CHM, Lima SCVC, Morais AHA, Lima AÂM, Maciel BLL. Intestinal Barrier Permeability in Obese Individuals with or without Metabolic Syndrome: A Systematic Review. Nutrients 2022;14:3649.
  • 11. Wang W, Uzzau S, Goldblum SE, Fasano A. Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci 2000;113:4435-40.
  • 12. Moreno-Navarrete JM, Sabater M, Ortega F, Ricart W, Fernández-Real JM. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS One 2012;7:e37160.
  • 13. Tajik N, Frech M, Schulz O, Schälter F, Lucas S, Azizov V, et al. Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis. Nat Commun 2020;11:1995.
  • 14. Tomov DG, Levterova BA, Mihaylova VN, Troev DM, Miteva MZ, Orbetzova MM. SERUM ZONULIN LEVELS IN HYPOTHYROID AND EUTHYROID PATIENTS WITH HASHIMOTO’S THYROIDITIS - A PILOT STUDY. Acta Endocrinol (Buchar) 2021;17:449-54.
  • 15. Leader B, Hegde A, Baca Q, Stone K, Lannon B, Seifer DB, et al. High frequency of discordance between antimüllerian hormone and folliclestimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers. Fertil Steril 2012;98:1037-42.
  • 16. Ohlsson B, Orho-Melander M, Nilsson PM. Higher Levels of Serum Zonulin May Rather Be Associated with Increased Risk of Obesity and Hyperlipidemia, Than with Gastrointestinal Symptoms or Disease Manifestations. Int J Mol Sci 2017;18:582.
  • 17. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997;18:107-34.
  • 18. Park SU, Walsh L, Berkowitz KM. Mechanisms of ovarian aging. Reproduction 2021;162:R19-33.
  • 19. Yilmaz Z, Oral S, Yurtcu N, Akpak YK, Celik S, Caliskan C. Predictive and Prognostic Value of Plasma Zonulin for Gestational Diabetes Mellitus in Women at 24-28 Weeks of Gestation. Z Geburtshilfe Neonatol 2022;226:384-90.
  • 20. Cohen J, Chabbert-Buffet N, Darai E. Diminished ovarian reserve, premature ovarian failure, poor ovarian responder--a plea for universal definitions. J Assist Reprod Genet 2015;32:1709-12.
  • 21. Zhang D, Zhang L, Yue F, Zheng Y, Russell R. Serum zonulin is elevated in women with polycystic ovary syndrome and correlates with insulin resistance and severity of anovulation. Eur J Endocrinol 2015;172:29- 36.
APA ÇELİK S, YURTCU N, Soyer çalışkan C, çelik s (2023). Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study. , 120 - 125. 10.4274/tjod.galenos.2023.26037
Chicago ÇELİK SEBAHATTİN,YURTCU NAZAN,Soyer çalışkan Canan,çelik samettin Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study. (2023): 120 - 125. 10.4274/tjod.galenos.2023.26037
MLA ÇELİK SEBAHATTİN,YURTCU NAZAN,Soyer çalışkan Canan,çelik samettin Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study. , 2023, ss.120 - 125. 10.4274/tjod.galenos.2023.26037
AMA ÇELİK S,YURTCU N,Soyer çalışkan C,çelik s Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study. . 2023; 120 - 125. 10.4274/tjod.galenos.2023.26037
Vancouver ÇELİK S,YURTCU N,Soyer çalışkan C,çelik s Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study. . 2023; 120 - 125. 10.4274/tjod.galenos.2023.26037
IEEE ÇELİK S,YURTCU N,Soyer çalışkan C,çelik s "Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study." , ss.120 - 125, 2023. 10.4274/tjod.galenos.2023.26037
ISNAD ÇELİK, SEBAHATTİN vd. "Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study". (2023), 120-125. https://doi.org/10.4274/tjod.galenos.2023.26037
APA ÇELİK S, YURTCU N, Soyer çalışkan C, çelik s (2023). Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study. Turkish Journal of Obstetrics and Gynecology, 20(2), 120 - 125. 10.4274/tjod.galenos.2023.26037
Chicago ÇELİK SEBAHATTİN,YURTCU NAZAN,Soyer çalışkan Canan,çelik samettin Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study. Turkish Journal of Obstetrics and Gynecology 20, no.2 (2023): 120 - 125. 10.4274/tjod.galenos.2023.26037
MLA ÇELİK SEBAHATTİN,YURTCU NAZAN,Soyer çalışkan Canan,çelik samettin Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study. Turkish Journal of Obstetrics and Gynecology, vol.20, no.2, 2023, ss.120 - 125. 10.4274/tjod.galenos.2023.26037
AMA ÇELİK S,YURTCU N,Soyer çalışkan C,çelik s Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study. Turkish Journal of Obstetrics and Gynecology. 2023; 20(2): 120 - 125. 10.4274/tjod.galenos.2023.26037
Vancouver ÇELİK S,YURTCU N,Soyer çalışkan C,çelik s Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study. Turkish Journal of Obstetrics and Gynecology. 2023; 20(2): 120 - 125. 10.4274/tjod.galenos.2023.26037
IEEE ÇELİK S,YURTCU N,Soyer çalışkan C,çelik s "Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study." Turkish Journal of Obstetrics and Gynecology, 20, ss.120 - 125, 2023. 10.4274/tjod.galenos.2023.26037
ISNAD ÇELİK, SEBAHATTİN vd. "Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study". Turkish Journal of Obstetrics and Gynecology 20/2 (2023), 120-125. https://doi.org/10.4274/tjod.galenos.2023.26037